查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566757

尿液檢查市場：按產品、應用和最終用戶分類：2024-2033 年全球機會分析和產業預測

Urinalysis Market By Product (Instruments, Consumables) , By Application (Disease Screening, Pregnancy & Fertility Testing) By End User (Hospitals, Clinical Laboratories, Home Care) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年尿液檢查市值為31億美元，預計2024年至2033年複合年成長率為8.3%，到2033年達到68億美元。

尿液檢查是一系列檢查尿液的測試，以檢測和治療多種疾病，包括尿道感染、糖尿病和腎臟疾病。尿液檢查包括尿液的物理和化學檢查以及細胞和顆粒成分的顯微鏡分析。透過分析尿液的物理、化學和微觀特性，醫療保健提供者可以評估其顏色、透明度和氣味，這可以提供有關代謝異常的第一個線索。

全球尿液檢查市場的成長主要是由於尿道感染(UTI) 的高發生率和腎臟疾病病例的增加，特別是在女性和老年人中。根據世界領先醫學研究中心之一的美國國立衛生研究院的數據，尿道感染患者人數從1990年的2.5225億增加到2019年的4.0461億，成長了60.40%。增加。此外，根據全球最具影響力的學術期刊之一《柳葉刀》2024 年 3 月發表的一項研究，全球整體有超過 8.5 億人患有腎臟疾病。此外，糖尿病盛行率的驚人上升使得需要定期進行尿液檢查以進行早期發現和管理，這是全球市場的主要驅動力。此外，老年人口的快速增加也對市場成長做出了重大貢獻。這是由於老化社會更容易患各種泌尿系統和腎臟疾病，導致老年醫學中擴大使用尿液檢查。然而，尿液檢查的高成本阻礙了市場的成長。此外，大多數國家沒有足夠的醫療設施來滿足其人口的需求，有限的醫療服務限制了市場的成長。相反，人工智慧和機器學習在數位尿液檢查系統中的整合預計將為預測期內的市場擴張提供利潤豐厚的機會。

全球尿液檢查產業按產品、最終用戶和地區進行細分。依產品分類，市場分為設備和消耗品。依用途又分為疾病篩檢和妊娠/不孕症檢測。依最終使用者分為醫院、臨床實驗室、居家醫療。從區域來看，我們對北美、歐洲、亞太地區和拉丁美洲/中東/非洲的市場進行了分析。

主要發現

按產品分類，消耗品領域在 2023 年佔據市場佔有率。

從應用來看，2023年疾病篩檢領域的市場佔有率最高。

從最終用戶來看，臨床測試領域是 2023 年的主要股東。

按地區分類，預計到 2033 年北美市場將領先市場。

該報告可以客製化（需要額外的費用和時間表）。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 擴大公司簡介列表
  • 歷史市場資料
  • 主要參與企業的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章尿液檢查市場：分產品

  • 市場概況
  • 用具
  • 消耗品

第5章尿液檢查市場：依應用分類

  • 市場概況
  • 疾病篩檢
  • 妊娠不孕不育檢查

第6章尿液檢查市場：依最終用戶分類

  • 市場概況
  • 醫院
  • 臨床實驗室
  • 居家醫療

第7章尿液檢查市場：按地區尿液檢查市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國尿液檢查市場
    • 加拿大尿液檢查市場
    • 墨西哥尿液檢查市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國尿液檢查市場
    • 法國尿液檢查市場
    • 英國尿液檢查市場
    • 義大利尿液檢查市場
    • 西班牙尿液檢查市場
    • 其他歐洲尿液檢查市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本尿液檢查市場
    • 中國尿液檢查市場
    • 澳洲尿液檢查市場
    • 印度尿液檢查市場
    • 韓國尿液檢查市場
    • 其他亞太尿液檢查市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西尿液檢查市場
    • 沙烏地阿拉伯尿液檢查市場
    • 南非尿液檢查市場
    • 其他拉丁美洲/中東/非洲尿液檢查市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Abbott Laboratories
  • Sysmex Corporation
  • Siemens Healthcare GmbH
  • ACON Laboratories, Inc.
  • Arkray Inc
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • F. Hoffmann-La Roche Ltd.
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
簡介目錄
Product Code: A00901

The urinalysis market was valued at $3.1 billion in 2023, and is projected to reach $6.8 billion by 2033, growing at a CAGR of 8.3% from 2024 to 2033.

Urinalysis is a series of test that involves the examination of urine to detect and manage a wide range of disorders, such as urinary tract infections, diabetes, and kidney diseases. It encompasses both physical and chemical examinations of urine, as well as microscopic analysis of its cellular and particulate components. By analyzing the physical, chemical, and microscopic properties of urine, healthcare providers can assess urine color, clarity, and odor, which can provide initial clues about metabolic disorders.

The growth of the global urinalysis market is majorly driven by high incidence of urinary tract infections (UTIs), especially among women and the elderly, and increase in cases of kidney disorders. According to the National Institute of Health-world's foremost medical research centers-the number of UTI cases increased by 60.40% from 252.25 million in 1990 to 404.61 million in 2019, and this number is expected to increase significantly in the coming future. Furthermore, as per a study published in March 2024 by Lancet-one of the world's highest-impact academic journals-more than 850 million individuals are suffering from kidney disease globally. Moreover, alarming rise in prevalence of diabetes necessitate regular urinalysis for early detection and management, which acts as a key driving force of the global market. In addition, surge in geriatric population notably contributes toward the growth of the market. This is attributed to the fact that the aging population is highly susceptible to various urinary and renal conditions, leading to increased utilization of urinalysis in geriatric healthcare. However, high cost associated with urinalysis hampers the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access restrain the market growth. On the contrary, integration of AI and ML in digital urinalysis systems is expected to offer remunerative opportunities for the expansion of the market during the forecast period.

The global urinalysis industry segmented into by product, end user, and region. By product, the market is divided into instruments, and consumables. On the basis of application, it is fragmented into disease screening, and pregnancy & fertility testing. Depending on end user, it is segregated into hospitals, clinical laboratories, and home care. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the consumable segment dominated the market share in 2023.

On the basis of application, the disease screening segment exhibited the highest market share in 2023.

Depending on end user, the clinical laboratories segment was the major shareholder in 2023.

Region wise, the market in North America is anticipated to lead the market by 2033.

Competition Analysis

Competitive analysis and profiles of the major players in the global urinalysis market include Abbott Laboratories, Sysmex Corporation, Siemens Healthcare GmbH, ACON Laboratories, Inc., Arkray Inc, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to capture maximum share and sustain the intense competition.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Instruments
  • Consumables

By Application

  • Disease Screening
  • Pregnancy Fertility Testing

By End User

  • Hospitals
  • Clinical Laboratories
  • Home Care

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Abbott Laboratories
    • Sysmex Corporation
    • Siemens Healthcare GmbH
    • ACON Laboratories, Inc.
    • Arkray Inc
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
    • F. Hoffmann-La Roche Ltd.
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: URINALYSIS MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Instruments
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Consumables
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: URINALYSIS MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Disease Screening
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Pregnancy Fertility Testing
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: URINALYSIS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Clinical Laboratories
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Home Care
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: URINALYSIS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Urinalysis Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Urinalysis Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Urinalysis Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Urinalysis Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Urinalysis Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Urinalysis Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Urinalysis Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Urinalysis Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Urinalysis Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Urinalysis Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Urinalysis Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. Australia Urinalysis Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. India Urinalysis Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Urinalysis Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Urinalysis Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Urinalysis Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Urinalysis Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Urinalysis Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Urinalysis Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Sysmex Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Siemens Healthcare GmbH
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. ACON Laboratories, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Arkray Inc
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. F. Hoffmann-La Roche Ltd.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Quidel Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Thermo Fisher Scientific Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Bio-Rad Laboratories, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments